Eyevance Pharmaceuticals Competitors and Similar CompaniesClear all

Eyevance Pharmaceuticals's competitors and similar companies include Bio-Tissue, Kedalion Therapeutics, Alkeus Pharmaceuticals, Surface Pharmaceuticals and Okogen.
Eyevance Pharmaceuticals
Eyevance Pharmaceuticals
Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment.
Bio-Tissue
Bio-Tissue
Bio-Tissue is a company that specializes in regenerative medicine for ocular surface disease and injury.
Kedalion Therapeutics
Kedalion Therapeutics
Kedalion Therapeutics is an ophthalmic drug company focused on the delivery of ocular medicines.
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals is a biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye.
Surface Pharmaceuticals
Surface Pharmaceuticals
Surface Pharmaceuticals is a biopharmaceutical company specializing in ocular surface disease.
Okogen
Okogen
Okogen is a company developing ophthalmic anti-infective drugs.
Founding Date
Founding Date
2017
Founding Date
1997
Founding Date
2015
Founding Date
2011
Founding Date
2017
Founding Date
2015
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Fort Worth, US HQ
Fort Worth, US
Locations
Miami, US HQ
Locations
Menlo Park, US HQ
Locations
Somerville, US HQ
Locations
HQ
Locations
Encinitas, US HQ
Melbourne, AU
Employees
Employees
3716% decrease
Employees
385
Employees
722% decrease
Employees
2
Employees
6
Employees
1025% increase

Funding

Latest funding round
Latest funding round
$ 30k (over 6 years ago)
Latest funding round
N/A
Latest funding round
$ 5m (almost 8 years ago)
Latest funding round
N/A
Latest funding round
$ 21m (almost 8 years ago)
Latest funding round
$ 10m (over 8 years ago)
Total funding raised
Total funding raised
$ 30k
Total funding raised
N/A
Total funding raised
$ 5m
Total funding raised
N/A
Total funding raised
$ 41m
Total funding raised
$ 10m
For sources of this data, please see the company profile

View Company Profiles

Bio-Tissue
HQ
Miami, US

Bio-Tissue is a company that specializes in regenerative medicine for ocular surface disease and injury.

View company
Kedalion Therapeutics
HQ
Menlo Park, US
Employees
7↓ 22% decrease

Kedalion Therapeutics is an ophthalmic drug company focused on the delivery of ocular medicines.

View company
Alkeus Pharmaceuticals
HQ
Somerville, US
Employees
2

Alkeus Pharmaceuticals is a biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye.

View company
Surface Pharmaceuticals
HQ
Employees
6

Surface Pharmaceuticals is a biopharmaceutical company specializing in ocular surface disease.

View company